Skip to main content
. 2018 Jul 30;9(8):213–226. doi: 10.1177/2040620718785363

Figure 1.

Figure 1.

Comparison of inhibitor-positive versus inhibitor-negative patients with reference to: (a) phenotype of patients with hemophilia A (b) blood products and factor administered, and (c) city-level distribution in relation to the annual factor intake.